3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
56
Lung Neoplasms
27
Parkinson Disease 4, Autosomal Dominant Lewy Body
5
Neoplasms
5
Neoplasm Metastasis
4
Colorectal Neoplasms
4
Colonic Neoplasms
3
Advanced Solid Tumors
3
Squamous Cell Carcinoma of Head and Neck
2
Rectal Neoplasms
2
Pancreatic Neoplasms
2
Non-squamous Non-small Cell Lung Cancer
2
Mesothelioma
2
Meningeal Carcinomatosis
2
Melanoma
2
Lung Diseases
2
Esophageal Neoplasms
2
Carcinoma
2
Adenocarcinoma of Lung
2
Uterine Cervical Neoplasms
1
Thoracic Neoplasms
1
Solid Tumors
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Pathologic Processes
1
Pathologic Complete Response
1
Ovarian Neoplasms
1
Interventions
Cyclophosphamide
9
fludarabine
7
Dexamethasone
7
pomalidomide
6
Rituximab
6
pembrolizumab
5
selinexor
4
obinutuzumab
4
glofitamab
4
Lenalidomide
4
daratumumab
3
belantamab mafodotin
3
Temozolomide
3
Gemcitabine
3
Etoposide
3
Bortezomib
3
zanubrutinib
2
venetoclax
2
tocilizumab
2
fludarabine phosphate
2
enzalutamide
2
cemiplimab
2
carfilzomib
2
abemaciclib
2
PF06821497
2
Mesna
2
Lisaftoclax
2
Injections
2
Immunotherapy, Adoptive
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
Pemetrexed
×
30 days
×
Clear all
No trials found.